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According to the prevailing paradigm, G-proteins are com-
posed of three subunits, an subunit withGTPase activity and a
tightly associated subunit complex. In the yeast Saccharomy-
ces cerevisiae there are two knownGproteins (Gpa1 andGpa2)
but only one G, which binds only to Gpa1. Here we show that
the yeast ortholog of RACK1 (receptor for activated protein
kinase C1) Asc1 functions as the G for Gpa2. As with other
known G proteins, Asc1 has a 7-WD domain structure, inter-
acts directly with the G in a guanine nucleotide-dependent
manner, and inhibits G guanine nucleotide exchange activity.
In addition, Asc1 binds to the effector enzyme adenylyl cyclase
(Cyr1), and diminishes the production of cAMP in response to
glucose stimulation. Thus, whereas Gpa2 promotes glucose sig-
naling through elevated production of cAMP, Asc1 has oppos-
ing effects on these same processes. Our findings reveal the
existence of an unusual G subunit, one having multiple func-
tions within the cell in addition to serving as a signal transducer
for cell surface receptors and intracellular effectors.
All cells must be able to detect extracellular signals and envi-
ronmental changes, and thenmount an appropriate response to
those signals. Specific stimuli include light, hormones, neuro-
transmitters, growth factors, and odorants. Guanine nucleoti-
de-binding proteins (G-proteins)2 are key intermediates in the
cellular signaling process, by coupling cell surface receptors
with intracellular effector proteins that generate cellular
responses (1, 2).
The prototypical heterotrimeric G-protein consists of , ,
and subunits and is coupled to a seven-transmembrane recep-
tor at the plasma membrane. Upon binding of agonist to the
receptor, a conformational change in the G subunit promotes
the release of GDP and binding to GTP. Guanine nucleotide
exchange triggers G disassociation from the G subunit,
after which both components are free to activate or inhibit
downstream effectors. The G subunit eventually hydrolyzes
GTP to GDP, resulting in re-association of the heterotrimer
complex and termination of signaling (2).
The G complex functions on many levels to promote, and
restrict, signaling at the plasma membrane. Most G com-
plexes help to recruit G subunits to the plasmamembrane and
promote coupling of the G protein to the receptor. The G
also functions as a guanine nucleotide disassociation inhibitor
to prevent spontaneous exchange of GTP for GDP by the G.
Finally, many G subunits regulate downstream effector
enzymes. G subunits regulate a wide variety of effector
enzymes including adenylyl cyclase, which converts ATP to the
second messenger cAMP (2–5).
The yeast Saccharomyces cerevisiae has two G-protein sig-
naling pathways. The first is the pheromone response pathway,
which is among the best characterized stimulus-response path-
ways of any system. In this example, signaling is activated by
secreted peptide pheromones. Cell surface pheromone recep-
tors activate a G-protein heterotrimer, in which the G (Ste4/
Ste18) is released and activates a downstream MAP (mitogen-
activated protein) kinase cascade at the plasma membrane
(6–8). The G subunit (Gpa1) activates a distinct effector, a
phosphatidylinositol 3-kinase (Vps34) located at the endoso-
mal membrane (9). These signaling events cooperate to pro-
mote mating or fusion of haploid a and  cells to form the a/
diploid.
A second G-protein signaling pathway mediates pseudohy-
phal differentiation in diploids and invasive growth in haploids.
Both of these responses aremediated by changes in the nutrient
status of the growth medium. In diploids, cells transition to
pseudohyphal differentiation upon limitation of nitrogen (10);
whereas in haploids, the cells transition to invasive growth
upon limitation of glucose (11) or other signals that cause an
increase in cAMP (12). Both differentiation behaviors are char-
acterized by altered budding, formation of long branching fila-
ments, as well as increased adherence and invasion of the sub-
stratum. Collectively, such filamentous growth may help to
direct new cells to sites of improved growth conditions.
The same cellular machinery is used for invasive growth in
both haploids and diploids, and isminimally comprised of a cell
surface receptor (Gpr1), a G protein (Gpa2), and the adenylyl
cyclase (Cyr1). All of these proteins are required for glucose-
induced cAMP signaling (13) and pseudohyphal differentiation
(14, 15). There is also evidence for physical association of glu-
cose with Gpr1 (16), Gpr1 with Gpa2 (17–19), and Gpa2 with
Cyr1 (20, 21). The resulting increase in cAMP promotes activa-
tion of the cAMP-dependent protein kinase (22–27). Cyr1 is
also directly activated by the small G protein Ras2 (28),
although this activation event occurs independently of Gpr1
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and Gpa2 (29). A second glucose-response pathway requires
Ras2, but leads to activation of a MAP kinase cascade com-
prised of Ste20, Ste11, Ste7, and Kss1 (30, 31). The glucose
receptor in this second pathway has not been identified,
although it does not appear to be Gpr1 and does not require
Gpa2 (14, 29, 32, 33).
Based upon sequence and structural comparison of typical G
protein subunits within the yeast genome, there appears to be
only one canonical G (Ste4/Ste18). Early research revealed
that Ste4 and Ste18 function exclusively in conjunction with
Gpa1 in the pheromone-response pathway (32). Two kelch-
repeat proteins, Gpb1 and Gbp2 (also known as Krh1 and
Krh2), were proposed to function as the G subunits for Gpa2
(34). However, further investigation has shown that these pro-
teins are not G-mimics but instead function to inhibit signal-
ing downstream of Gpa2 (21, 35–37). Using bioinformatic,
genomic, biochemical, and pharmacological approaches we
have identified Asc1 as the G for Gpa2, and demonstrate a
critical role for Asc1 in the glucose signaling pathwaymediated
by adenylyl cyclase.
EXPERIMENTAL PROCEDURES
Strains and Plasmids—Standard methods for the growth,
maintenance, and transformation of bacteria and yeast and for
themanipulation of DNAwere used throughout. Yeast Saccha-
romyces cerevisiae strains used in this study were BY4741
(MATa leu2 met15 his3 ura3) and BY4741-derived gene
deletionmutants (Invitrogen), and1278-based invasive strain
(MATa leu2 ura3, from Joseph Heitman, Duke University)
and 1278-derived gene deletion mutants. Yeast shuttle plas-
mids pRS315-ADH (CEN, ampR, LEU2, ADH1 promoter/ter-
minator) and pRS316-ADH (CEN, ampR, URA3, ADH1 pro-
moter/terminator) (38) were modified by PCR amplification of
the gene of interest and subcloned such that a FLAG (GATTA-
CAAGGATGACGACGATAAG) or Myc (GAACAAAAATT-
GATTTCTGAAGAAGATTTG) epitope could be added to the
5 coding sequence of any gene with a SacI site engineered in-
frame with the open reading frame. Previously described yeast
shuttle plasmids used in this study are pAD4M-GST (38) and
pAD4M-GPA2-GST (39). The FRE-lacZ transcription reporter
plasmid was generously provided by Gerald Fink (40). The
Escherichia coli expression plasmids were constructed by PCR
amplification of the ASC1 (also known as CPC2) and GPA2
coding regions and annealed into gapped ligation-independent
cloning (LIC) vectors pLIC-HIS and/or pLIC-GST (from John
Sondek, University of North Carolina).
Purification of Proteins from Yeast—Transformed strains
were grown to A600 nm  1.0, harvested by centrifugation, and
resuspended in FLAGLysis Buffer (50mMTris, pH 8.0, 150mM
NaCl, 1 mM EDTA, 3 mM MgCl2, 25 mM -glycerolphosphate,
0.1% Triton-X100, protease inhibitor mixture pellets (Roche, 1
pellet/25ml of buffer)). Cells were lysed by vortexing with glass
beads 10 times, 30 s each, with cooling on ice for 1 min in
between. Lysates were rocked at 4 °C for 30 min to solubilize
membrane proteins, and centrifuged at 6,000  g for 1 min and
again for 30min to remove insolublematter. Protein content of
the supernatant was determined by DC Protein Assay (Bio-
Rad), equalized, and mixed with 20 l of M2 FLAG Affinity
Resin (Sigma) equilibrated with FLAG Lysis Buffer. After 2 h of
gentle rocking at 4 °C, the resin was collected by centrifugation
at 500  g for 1 min. Resin was washed 4 times with 1.5 ml of
FLAGLysis Buffer and boundproteinswere elutedwith 75l of
2 SDS-PAGE sample buffer at 100 °C for 5 min. For experi-
ments comparing binding between GDP or GDP-AlF4 loaded
G proteins, 10 M GDP or 10 M GDP with 30 M AlCl3 and
10 mM NaF, respectively, was added to the lysis and wash buff-
ers. Samples were resolved by SDS-PAGE and immunoblotting
with 9E10 anti-Myc (41) and anti-FLAGmonoclonal antibodies
(Sigma), in conjunction with enhanced chemiluminescence
detection of horseradish peroxidase-conjugated secondary
antibodies.
Expression and Purification of Proteins from E. coli—pLIC-
HIS-ASC1, pLIC-GST-ASC1, andpLIC-HIS-GPA2were trans-
formed into E. coli strain BL21. Overnight cultures grown at
37 °C from single colonies in Luria Broth containing 100 g/ml
carbenicillin were diluted into freshmedium toA590 nm  0.1 at
37 °C. Once the cultures reachedA590 nm  0.6 they were trans-
ferred to 25 °C and grown to A590 nm  0.9. Protein expression
was induced by addition of 25mM isopropyl -D-1-thiogalacto-
pyranoside for an additional 5 h. Cells were harvested by cen-
trifugation for 15min at 6,000 g. Cells expressing GST fusion
proteins were resuspended in GST Lysis Buffer (10 mM
Na2HPO4, 1.8 mM NaH2PO4, 1 M NaCl, 2.5 mM KCl, 1 mM
EDTA, 0.1% Triton X-100, 1 mM dithiothreitol, protease inhib-
itor mixture pellets). Cells expressing His fusion proteins were
resuspended in His Lysis Buffer (50 mM Tris, pH 8.0, 1 M NaCl,
0.1% Triton X-100, 15 mM imidazole, 1 mM dithiothreitol, pro-
tease inhibitor mixture pellets) at 4 °C and the cells were lysed
using an Emulsiflex-C5 Homogenizer (Avestin Inc.). 50 g/ml
of DNase I was added to the lysates and gently rocked at 4 °C for
30min followed by centrifugation at 12,000 g for 30min.GST
lysates weremixedwith glutathione-Sepharose 4 Fast Flow (GE
Healthcare) equilibrated with GST Lysis Buffer; His lysates
weremixed with nickel-Sepharose 6 Fast Flow (GEHealthcare)
equilibrated in His Lysis Buffer. Lysates were incubated with
beads for 2 h at 4 °C with gentle rocking. The beads were then
loaded into a chromatography column and washed with appro-
priate buffer until the flow through contained no protein as
detectable by the DC Protein Assay (Bio-Rad). GST fusion pro-
teins were eluted with GST Lysis Buffer supplemented with 10
mM reduced glutathione, and then exchanged into Storage
Buffer (50 mM Tris-Cl, pH 8.0, 150 mM NaCl, 5% glycerol, 0.1%
Triton X-100, 1 mM dithiothreitol); His fusion proteins were
eluted with His Lysis Buffer supplemented with 250 mM
imidazole and then exchanged into Storage Buffer. Elution
and Storage Buffers for the purification of His-Asc1 included
25% glycerol, whereas all other buffers contained 5% glyc-
erol. All buffers for the purification of Gpa2 included 10 M
GDP. Purified proteins were concentrated using a Vivaspin
(Vivascience) concentrator.
In Vitro Binding Assay—Purified His-Gpa2 (final concentra-
tion 200 nM) was reconstituted with 10-fold molar excess GST-
Asc1 in 1.0ml of BindingBuffer (20mMTris-Cl, pH8.0, 150mM
NaCl, 5% glycerol, 1 mM dithiothreitol, 3 mM MgCl2, 10 M
GDP) with or without 10 mM NaF and 30 M AlCl3 (AlF4) and
gentlymixed for 30min at 4 °C. 50l of Glutathione-Sepharose
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4 was equilibrated with Binding Buffer and thenmixed with the
protein samples for 2 h at 4 °C with gentle rocking. Beads were
collected by centrifugation at 500  g for 1 min and washed 4
times with Binding Buffer. Bound proteins were eluted with 50
l of 2 SDS-PAGE buffer at 100 °C for 5 min and resolved by
SDS-PAGE and immunoblotting with anti-GST (from Joan
Steitz, Yale University) or anti-His6 (Qiagen) antibodies.
Invasive Growth Assay—5 l of an overnight saturated cul-
ture of the indicated strains from the 1278 background
were spotted onto a YPD plate and grown at 30 °C for 3 days.
Total growth of strains was imaged, and then the plate was
gently washed under a stream of water to remove non-inva-
sive cells from the surface of the agar. The plates were
allowed to dry briefly before re-imaging to document inva-
sive growth.
GTPS Binding Assay—200 nM His-Gpa2 was preincubated
alone orwith either 200 nMor 1MHis-Asc1 in BODIPYBuffer
(10 mM Tris, pH 8.0, 1 mM EDTA, 10 mM MgCl2) for 30 min at
27 °C.Measurement of BODIPYFL-GTPS (Molecular Probes,
Inc.) binding to His-Gpa2 was determined as described previ-
ously (42).
Steady-state GTP Hydrolysis Assay—200 nM His-Gpa2 was
preincubated alone or with 200 nM, 1 M, or 4 M His-Asc1 in
Hydrolysis Buffer (50 mM HEPES, pH 8.0, 1 mM EDTA, 3 mM
dithiothreitol, 0.025% Lubrol) for 30 min. The rate of GTP
hydrolysis was determined as described previously (43).
Transcription Reporter Assay—Strains were transformed
with the FRE-lacZ reporter plasmid, grown in selective SCD-
LEU medium overnight, and then diluted to A600 nm  0.2 in
fresh medium and grown for an additional 20 h at 30 °C. Cells
were collected by centrifugation and washed twice with sterile
water and once with MES Buffer (10 mM MES, pH 8.0, 0.1 mM
EDTA) and finally resuspended in MES Buffer and incubated
for 2 h at 30 °C with shaking. Cultures were diluted to equalize
density, and 90 l of cells were mixed with 10 l of D- or L-glu-
cose at 0–100 mM final concentration, and incubated for 90
min at 30 °C. -Galactosidase activity was measured as
described previously (44).
cAMP Production Assay—cAMP was measured using a
cAMP Biotrak EIA kit (GE Healthcare) as described previously
(15).
MAP Kinase Phosphorylation Assay—Overnight cultures
grown in YPD-rich medium were diluted to A600 nm  0.2 in
fresh YPD and grown for an additional 20 h at 30 °C. Cells were
collected by centrifugation and washed twice with sterile water
and once with MES Buffer and finally resuspended in MES
Buffer and incubated for 2 h at 30 °C with shaking. After 2 h the
cultures were treated with 100mM D- or L-glucose and 750l of
culture was collected at the indicated times by rapidly mixing
with 750l of 2 trichloroacetic acid Lysis Buffer (20mMTris-
HCl, pH 8.0, 20% trichloroacetic acid, 50 mM NH4OAc, 2 mM
Na2EDTA) and flash frozen in liquid nitrogen. Protein was
extracted as described previously (45) and quantified using the
DC protein assay (Bio-Rad). A total of 50 g of protein extracts
was resolved by 12.5% SDS-PAGE and immunoblotting with
p44/42 MAPK antibodies (Cell Signaling Technology) (46).
RESULTS
The 7-WD Repeat Protein Asc1 Interacts Directly with the
Inactive Form of G Gpa2—Our objective in this study was
to identify the G protein for Gpa2. The crystal structures of
the mammalian G subunits of transducin revealed that
the G protein folds into a seven-bladed propeller structure
(-propeller) based around 7-WD repeat motifs (47). The
WD repeat is a conserved domain, 40–60 amino acids in
length that begins with glycine-histidine and ends with tryp-
tophan-aspartic acid (WD). Because all previously identified
G subunits have the characteristic 7-WD domain structure,
we began by searching for any gene product bearing this
signature motif. We did not limit our search to proteins of
unknown function, because WD repeat-containing proteins
often have broad or even multiple functions, including roles in
signal transduction, cell cycle control, mRNA splicing, and
transcriptional repression (48). In yeast alone, there are an esti-
mated 104 proteins that containWD repeats (49). By searching
the SMART (Simple Modular Architecture Research Tool)
data base (49) we identified 21 proteins predicted to have either
seven WD repeats, or in some cases six repeats with an addi-
tional segment large enough to contain a seventh (less-con-
served) WD domain.
We then considered which of the 21 candidate proteins
could function in the manner of known G proteins. In addi-
tion to their characteristic 7-WD structure, G proteins (i)
bind directly to G subunits; (ii) bind preferentially to the
inactive GDP-bound form of the G protein; (iii) function as
guanine nucleotide disassociation inhibitors; and, in most
cases (iv) regulate downstream signaling events (3). We ini-
tially searched for proteins able to bind to Gpa2 in vivo. All
21 candidates were fused to the FLAG epitope and individ-
ually expressed in yeast together with Gpa2 fused to GST.
Each of the FLAG fusion proteins was then immunoprecipi-
tated. The presence of Gpa2 in the resulting immunoprecipi-
tates was detected by SDS-PAGE and immunoblotting using
anti-GST antibodies. This analysis identified two proteins
capable of co-precipitating Gpa2: Asc1 and Prp4 (data not
shown).
We next sought to determine whether either Asc1 or Prp4
binds preferentially to the inactive (GDP bound) form of
Gpa2. Asc1 and Prp4 were again immunoprecipitated, this
time in the absence or presence of AlF4. GDP-AlF4 mimics
the transition state for GTP hydrolysis, and induces a con-
formation resembling that of the activated G protein (2). In
this comparison, Prp4 bound equally to both the active and
inactive forms of Gpa2, and was eliminated from further
consideration. In contrast, Asc1 bound almost 4-fold more
Gpa2-GDP thanGpa2-GDP-AlF4 (Fig. 1A). Thus Asc1 binds
preferentially to the inactive form of Gpa2, in the manner of
known G-G interactions.
Having shown that Asc1 binds preferentially to inactive
Gpa2, we sought to determine whether the interaction is direct.
To this end we purified GST-Asc1 and His6-Gpa2 from E. coli,
and reconstituted the proteins in the presence of GDP or GDP-
AlF4. Asc1 was then re-purified by glutathione affinity chro-
matography, and any co-purifyingGpa2was detected by immu-
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noblotting with anti-His6 antibodies. As shown in Fig. 1B, Asc1
binds directly to Gpa2, and binds preferentially to the inactive
(GDP-bound) form of the protein.
Disruption of Gpr1 or Gpa2 activity has been reported to
impair specific growth behavior phenotypes, including diploid
pseudohyphal and haploid invasive growth (14, 15). As we have
shown that Asc1 interacts directly with Gpa2 we sought to
establish whetherASC1-deficient strains have a phenotype in a
Gpa2 signaling pathway, and to rule out the possibility of func-
tional redundancy with another G-like protein. Therefore, we
examined the ability of asc1 cells to sustain the invasive
growth response. Fig. 1C shows that ASC1 is required for inva-
sive growth. As has been shown previously, GPR1 (15), GPA2
(37), and STE12 (50) are likewise required for invasive growth.
In contrast, the wild-type and rgs2 strains are invasive. These
results show that Asc1 both interacts with Gpa2 and is impor-
tant in Gpa2-mediated signaling.
Asc1 Functions as a Guanine Nucleotide Dissociation
Inhibitor—Having shown that Asc1 binds, in the manner of
known G subunits, to Gpa2, we next sought to characterize
Asc1 biochemically. G proteins inhibit the spontaneous
exchange of GTP for GDP on their cognate G. To determine
whether Asc1 has the same function toward Gpa2, we meas-
ured the rates of GTP binding and hydrolysis. In the absence of
receptors, the rate-limiting step in the GTPase cycle is the
release of GDP (2, 51); thus if Asc1 reduces the spontaneous
rate of GDP release, the rates of GTP binding and hydrolysis
should be correspondingly diminished.
We first determined if Asc1 affects the rate of spontaneous
GTP binding toGpa2. For these experiments we used a fluores-
cent non-hydrolyzable analogue of GTP (BODIPY-GTPS).
The fluorescence of this ligand is quenched in solution but
increases dramatically upon binding to G. Therefore, the rate
of GTP binding can be easily quantified by fluorometry (52).
Purified recombinant His6-Gpa2, either alone or in the pres-
ence of a 5-fold molar excess of purified recombinant His6-
Asc1, was mixed with BODIPY-GTPS and the resulting
increase in fluorescence was monitored over time. The initial
rate of nucleotide exchange (as measured by relative fluores-
cence per second for the first 60 s) for Gpa2 alone was 0.096 
0.006 relative fluorescence units/s, and in the presence of Asc1
the rate was reduced to 0.061  0.003 relative fluorescence
units/s (Fig. 2A).
We thenmeasured GTP hydrolysis under steady state con-
ditions. For this experiment we used purified Gpa2 (final
concentration 200 nM), either alone or with Asc1 in equimo-
lar, 5-fold excess, or 20-fold excess concentrations. The pro-
teins were incubated with [-32P]GTP, and the amount of
32P released was determined over time. As shown in Fig. 2B,
increasing concentrations of Asc1 yielded a corresponding
decrease in the rate of [-32P]GTP hydrolysis, from 0.78 (no
Asc1) to 0.42 pmol/min (equimolar Asc1), 0.34 pmol/min
(5-fold excess of Asc1), and 0.26 pmol/min (20-fold excess of
Asc1). Based on the results of the binding and hydrolysis
assays, we conclude that Asc1 functions biochemically to
inhibit Gpa2 guanine nucleotide exchange, in the manner of
known G proteins.
Asc1 Negatively Regulates Glucose-mediated Signaling—
Having determined that Asc1 binds to Gpa2, has a phenotype
in Gpa2 mediated signaling, and regulates the biochemical
activity of Gpa2, we next sought to determine the physiolog-
ical role of Asc1 in glucose signaling. Two signaling pro-
cesses, linked through Ras2, have been reported to be acti-
vated by extracellular glucose. In the first case, glucose binds
to an unknown receptor and promotes activation of a MAP
kinase cascade that includes Ste20, Ste11, Ste7, and Kss1 (30,
31). In the second case, glucose binds to the receptor Gpr1
(16), which activates the G protein Gpa2, which in turn
activates the adenylyl cyclase Cyr1 (13–27, 53, 54). Activa-
tion of Cyr1 leads to a rapid and transient increase in cellular
concentrations of cAMP (19).
We first investigated the glucose-response pathway lead-
ing to Kss1 MAP kinase activation. It is not known how
glucose activates this particular pathway, but it appears to
terminate with transcription factors that bind filamentous
FIGURE 1. Asc1 interacts with the inactive GDP-bound form of the G
Gpa2 and is required for invasive growth. A, co-immunoprecipitation of
Gpa2 with Asc1 from yeast. Whole cell extracts from wild-type cells trans-
formed with plasmids containing FLAG-ASC1 (pRS316-ADH) and either
GPA2-GST or GST alone (pAD4M) were immunoprecipitated (IP) in buffer con-
taining either GDP or GDP-AlF4
 with anti-FLAG beads, washed, eluted with
SDS-PAGE sample buffer, and resolved by SDS-PAGE and immunoblotting
(IB). Co-purifying proteins were detected with anti-GST antibodies. Relative
binding (% of maximum) was determined by densitometry. Applied samples
are 10% (50 ng) of the starting protein sample used for precipitation. B, co-
purification of Gpa2 with Asc1 using recombinant proteins purified from
E. coli. 0.2 nmol of Gpa2 was preincubated with 2.0 nmol of Asc1 for 30 min
and then repurified by GST-Sepharose affinity chromatography. Samples
were eluted and resolved as described above, except that Gpa2 was detected
with anti-His6 antibodies. C, invasive growth assay. Cells containing the indi-
cated deletions from the 1278-based strain were spotted onto YPD plates
and grown for 3 days at 30 °C (total growth) and then gently washed to detect
invasive growth.
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response elements (FREs) (30, 31, 55). To determine whether
Asc1 affects glucose-mediated signaling through Kss1 we
measured gene transcription activity using an FRE(TEC1)-
lacZ reporter (40, 56). This reporter responds to activation
by the transcription factor heterodimer composed of Ste12
and Tec1, which is in turn activated by Kss1 (40, 57–59). In
this method cells must first be grown to saturation and then
further starved in nutrient-free medium to impose glucose
exhaustion. Wild-type as well as gpr1, gpa2, ste20, and
asc1 mutant strains were grown to saturation, starved, and
then stimulated with D-glucose for 45 min. Induction of lacZ
(-galactosidase) was determined spectrophotometrically.
Compared with wild-type cells, the asc1 strain is greatly
more sensitive to glucose (EC50  0.95 versus 8.08 mM, Fig.
3A). Moreover, the asc1 strain also exhibited substantially
elevated basal andmaximal transcription activity. The gpr1
and gpa2 strains had diminished responses and the ste20
strain exhibited no response to glucose (Fig. 3B). The phe-
notype of the asc1 strain was rescued by transforming cells
with a plasmid containing a genomic copy of ASC1 (data not
shown). Yeast are only able to utilize the D-enantiomer of
glucose (16); as expected, cells treated with L-glucose exhib-
ited no -galactosidase induction (data not shown). These
results indicate that Asc1 represses new gene transcription
under basal as well as glucose-stimulated conditions; and
that Gpr1 and Gpa2 do not significantly contribute to glu-
cose signaling through the MAP kinase cascade. This result
is in agreement with previous studies showing that Gpr1 and
Gpa2 are not required to activate Kss1 (60).
In the pheromone response path-
way, the G protein Ste4 binds to
Ste20, and this binding is required
for Fus3MAPkinase activation (61).
Therefore, we asked if the G pro-
tein Asc1 has a similar ability to
bind Ste20, and perhaps in this way
serves to regulate Kss1. To test this
hypothesis, FLAG-tagged Ste20 was
co-expressedwithMyc-taggedAsc1
in yeast and Ste20 was purified
using an anti-FLAG affinity resin.
As shown in Fig. 3C, Asc1 copurifies
with Ste20. To determine whether
Asc1 interaction is required for glu-
cose signaling, we determined the
physiological consequences of dis-
rupting this interaction. We com-
pared the glucose activation of Kss1
in a wild-type strain and isogenic
mutant strains lacking components
of theG-protein signaling apparatus
including ASC1. Kss1 kinase activa-
tion was monitored using phospho-
p42/p44 antibodies, which recog-
nize the dually phosphorylated and
activated forms of both Kss1 and
Fus3 (46). As shown in Fig. 3D, glu-
cose stimulation of wild-type cells
led to Kss1 activation within 8 min, and maximal induction by
12 to 16 min. The asc1 strain showed a similar activation
trend, however, there was amuch higher level of basal as well as
maximal Kss1 phosphorylation. The gpr1 and gpa2 strains
showed similar responses to wild-type (Fig. 3D). Again, the
asc1 signaling phenotype was rescued by transformation of
the cells with a plasmid containing a genomic copy of ASC1
(data not shown).
These results indicate that Asc1 interacts with Ste20 and
functions to repress basal MAP kinase activity, without sub-
stantially alteringMAP kinase activation in response to glucose
stimulation. However, this is in contrast to Ste4, where binding
to Ste20 leads to activation of MAP kinase signaling (61). We
hypothesize that the diminished transcriptional response seen
in the gpr1 and gpa2 strains is caused by release of Asc1,
allowing it to interact instead with Ste20 and thereby inhibit
MAP kinase signaling.
We then considered a role for Asc1 in the second branch of
the glucose signaling pathway, in this case leading to activa-
tion of adenylyl cyclase. In mammalian cells, it is well estab-
lished that G and G proteins can act on the same effector
enzyme including most isoforms of adenylyl cyclases. For
example, type I adenylyl cyclase is activated by Gs and
inhibited by G, whereas type II adenylyl cyclase is acti-
vated by both Gs and G (5). The yeast adenylyl cyclase is
activated in response to glucose stimulation, and this process
requires the glucose receptor Gpr1 and the G subunit Gpa2
(13–27, 53, 54). Given that many G proteins interact with
adenylyl cyclases (3, 5), we investigated whether Asc1 also
FIGURE 2. Asc1 functions as a guanine nucleotide dissociation inhibitor. In vitro GTP binding assays
using recombinant protein purified from E. coli. A, 200 nmol of Gpa2 was preincubated either alone or with
1000 nmol of Asc1 for 30 min. Rate of BODIPY-GTPS binding to Gpa2 was then determined as the increase
in fluorescence (left panel). Initial rates are 0.093 relative fluorescence units (RFU)/s for Gpa2 and 0.061
relative fluorescence units/s for Gpa2 plus Asc1 (right panel). B, steady-state GTP hydrolysis assay. 200
nmol of Gpa2 was preincubated either alone or with 200, 1000, or 4000 nmol of Asc1 for 30 min. Rate of
hydrolysis was determined by measuring the release of free 32P over time. A representative time course is
shown for Gpa2 alone and Gpa2 with 4000 nmol of Asc1 (left panel). Rate of hydrolysis shown for all
conditions is shown in the right panel. All data are representative of two or more separate experiments.
Error bars  S.E.
Asc1 Is a Multifunctional G Subunit
25172 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 282 • NUMBER 34 • AUGUST 24, 2007
interacts with Cyr1. Myc-tagged Asc1 was co-expressed with
FLAG-tagged Cyr1, and Cyr1 was purified using an anti-
FLAG affinity resin. Co-purifying Asc1 was then identified
by immunoblotting with anti-Myc antibodies. As shown in
Fig. 4A, Asc1 binds to Cyr1, and binding occurs even in the
absence of Gpa2 expression (i.e. the complex was still
detected in gpa2 mutant cells). We then determined the
effect of this interaction on cAMP production. Wild-type as
well as gpr1 and asc1 mutant yeast strains were grown to
saturation, starved for 2 h, and treated with glucose. As
shown in Fig. 4B, addition of glucose to wild-type cells
caused a rapid and transient increase in cAMP, and this
response was largely absent in the gpr1 mutant. In stark
contrast, the asc1 strain exhibited a markedly elevated
response, demonstrating that Asc1 inhibits Cyr1 cAMP
production.
Taken together, these results
indicate that Asc1 is a G protein
that links the glucose receptor Gpr1
to the intracellular effector Cyr1.
Asc1 also interacts with Ste20 to
repress basal MAP kinase signaling,
but this interaction has relatively
modest effects on the glucose
response pathway, mainly in damp-
ening the basal activation state of
the pathway.
DISCUSSION
Gpa2 was first identified in 1988
(62) and the yeast genome was fully
sequenced by 1996 (63), but as yet
no cognate G has been identified.
We have now identified Asc1 as the
G protein for Gpa2. Asc1 shares
many of the characteristics of
known G proteins. Structurally,
Asc1 contains 7 WD repeats. Func-
tionally, Asc1 interacts directly with
the GDP-bound form of Gpa2,
inhibits Gpa2 guanine nucleotide
exchange, and regulates a known
secondmessenger in the glucose-re-
sponse pathway.
Asc1 also exhibits some impor-
tant structural and functional differ-
ences with known G subunits.
With respect to structure, Asc1
lacks a coiled-coil domain normally
found at the N terminus of G pro-
teins. This N-terminal region repre-
sents an important determinant for
binding to G subunits (2). Thus we
speculate that Asc1 does not associ-
ate with anyG-like protein. In sup-
port of this concept, Asc1 is a cyto-
plasmic protein, whereas G
subunits are generally responsible
for targeting G and G specifically to the plasma membrane
(more specifically, prenylation of G anchors the G dimer to
the membrane) (3). Moreover, Asc1 can be stably expressed in
E. coli despite the absence of anyG binding partner. Other G
proteins must assemble with a G protein to be stably
expressed or purified (2).
Asc1 also has several unique functional characteristics. Asc1
was first identified as a transcription suppressor that associates
with the 40 S ribosomal subunit (64). Asc1 has also been shown
to be an integral component of the ribosome, and is required for
some protein-protein interactions within the ribosome com-
plex (65). In a large-scale systematic screen of the yeast pro-
teome, Asc1 was identified in numerous separate protein com-
plexes having a broad range of functions, including membrane
biogenesis and function, protein synthesis and turnover, RNA
metabolism and transcription, DNA maintenance, and chro-
FIGURE 3. Asc1 interacts with Ste20 and negatively regulates basal signaling of the MAP kinase branch of
the glucose signaling pathway. A, D-glucose-dependent transcriptional induction (FRE(TEC1) promoter, lacZ
reporter) was measured in wild-type, gpr1, gpa2, ste20, and asc1 cells. Cells were treated with the indi-
cated concentrations of glucose for 60 min and the resulting -galactosidase activity was measured spectroflu-
orometrically. The data shown are representative of two independent experiments performed in triplicate.
Error bars  S.E. B, same graph as in A with the y axis expanded to the scale of the maximum wild-type response.
C, Asc1 interacts with Ste20. gpa2 cells transformed with the indicated plasmids were grown to mid-log
phase, lysed, and the detergent-solubilized protein was immobilized on FLAG beads, washed, and eluted with
SDS-PAGE sample buffer. Bound proteins were detected by immunoblotting (IB) with antibodies against the
Myc or FLAG epitopes. 5% (25 ng) of the soluble cell lysate was probed with antibodies against FLAG or Myc to
confirm equivalent levels of protein expression. D, glucose-dependent Kss1 activation. BY4741 wild-type,
gpr1, gpa2, and asc1 cells were grown to saturation, washed, and further starved for 2 h. At the time points
indicated, samples were removed and flash frozen in liquid nitrogen. Proteins were extracted with trichloro-
acetic acid and 50 ng of protein was resolved by SDS-PAGE and immunoblotting against a phospho-specific
p44/42 antibody. IP, immunoprecipitation.
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matin structure (66, 67). We have also shown previously that
Asc1 interacts weakly with the G in the pheromone response
pathway, Gpa1, and deletion of ASC1 results in cells that are
slightly more sensitive to pheromone stimulation (39). Such
diversity of functionhas noprecedent among themore “typical”
G subunits. Notably, Asc1 is a very highly expressed protein
with an estimated 330,000 copies per cell (68, 69). This repre-
sents a 	70-fold excess over Gpa2, with an estimated 4570
copies per cell (68). This difference likely reflects the broad
array of functions ascribed to Asc1, most of which are likely to
be independent of Gpa2.
Asc1 is closely related to the mammalian protein RACK1,
which like Asc1 has diverse functions and is expressed at high
levels. RACK1 was first identified as a adaptor for protein
kinase C, and was proposed to function in signal transduction
(70). RACK1 has since been shown to interact with the G-pro-
tein transducin, to repress gene expression as a component of
the 40 S ribosome, and to regulate G1/S progression by sup-
pressing Src kinase activity (71–75). RACK1 andAsc1 have also
been shown to be functionally interchangeable within the yeast
40 S ribosome (76).
Asc1 joins a small but growing list ofmultifunctional or atyp-
ical G proteins (77). Recently Gpa1was shown to bind directly
to Vps15 in a GDP-dependent manner. Vps15 is a large protein
that contains a protein kinase domain near its N terminus and a
7-WD domain near the C terminus. The 7-WD domain is pre-
dicted to fold into a -propeller structure, in a similar manner
to that ofG proteins (9). Vps15 also binds to the phosphatidyl-
inositol 3-kinase Vps34, and this binding is required for Vps34
catalytic activity (9). The Asc1 ortholog inCryptococcus neofor-
mans, Gib2, has been identified as an atypical G that functions
as a positive regulator of cAMP signaling to regulate melaniza-
tion and capsule formation associated with virulence (78).
These findings are in contrast to our findings that Asc1 is a
negative regulator of signaling via cAMP. That study also iden-
tified two atypicalG subunits,Gpg1 andGpg2. It is not known,
however, if Gib2 has other functions typically ascribed to G
subunits, such as receptor coupling, inhibition of guanine-nu-
cleotide exchange, or effector modulation. A third atypical G
subunit has recently been described in Schizosaccharomyces
pombe. This protein, Gnr1, interacts with the G from the
pheromone response pathway and negatively regulates phero-
mone signaling (79). Gnr1 functions similarly to Asc1 in that it
negatively regulates signaling but is not required to initiate the
signaling event.
In summary, we have identifiedAsc1 as theG subunit in the
yeast glucose signaling pathway (Fig. 5). Asc1 binds directly to
GDP-Gpa2 and inhibits Gpa2 guanine nucleotide exchange
activity. Asc1 also binds to the downstream effector Cyr1, and
does so independently of Gpa2 expression. Interaction with
Cyr1 appears to result in diminished cAMP production. Asc1
also interacts with a second downstream effector Ste20 and the
result of this interaction is repression of basal signaling via the
MAP kinase branch of the glucose signaling apparatus.
There is an apparent contradiction between the Gpa2-medi-
ated growth (Fig. 1C) and upstream signaling phenotypes (Figs.
3, A and D, and 4B). Whereas ASC1 is required for invasive
growth, as is GPA2, the MAP kinase and cAMP signaling phe-
FIGURE 4. Asc1 interacts with the adenylyl cyclase Cyr1 and negatively
regulates the cAMP/PKA branch of the glucose signaling pathway.
A, Asc1 interacts with Cyr1. gpa2 cells transformed with the indicated plas-
mids were grown to mid-log phase, lysed, and the detergent-solubilized pro-
tein was immobilized on FLAG beads, washed, and eluted with SDS-PAGE
sample buffer. Bound proteins were detected by immunoblotting (IB) with
antibodies against the Myc or FLAG epitopes. 5% (25 ng) of the total soluble
cell lysate was probed with antibodies against FLAG and Myc to confirm
equivalent levels of protein expression. B, glucose-dependent cAMP produc-
tion. Wild-type, gpr1, and asc1 cells were grown to saturation, washed,
and further starved for 2 h. Yeast were stimulated with 100 mM glucose
and production of cAMP was determined at each time point. Error bars 
S.E. IP, immunoprecipitation.
FIGURE 5. Model of glucose signaling by the MAP kinase and cAMP/PKA
signaling pathways. Under basal conditions, Asc1 functions to (i) inhibit
signaling through the MAP kinase module possibly through its interaction
with Ste20; and (ii) to inhibit signaling through the cAMP/PKA module by
acting as a nucleotide disassociation inhibitor toward Gpa2. Under glucose
stimulation, Asc1 functions to (i) inhibit signaling through the MAP kinase
module, and (ii) inhibit production of cAMP by Cyr1.
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notypes for Gpa2 and Asc1 are opposite: Asc1 restricts these
signaling events whereas, Gpa2 promotes them. We speculate
that this is due to the asc1 strain being over-responsive to the
presence of glucose. The invasive response is caused by a limi-
tation of glucose; however, in strains lackingASC1 the signaling
is amplified such that the cells do not detect the glucose limita-
tion and therefore do not become invasive. A second explana-
tion is that a non-G function of Asc1 could be required for
invasive growth, but not for glucose-stimulated signaling.
Having identified Asc1 as the G for Gpa2, we are now well
positioned to determine how nutritional signals are detected,
and how those signals are transduced into changes in cell
homeostasis. More generally, the recent discovery of multi-
functional G proteins, includingVps15 andAsc1 in yeast, sug-
gests that the superfamily of G subunits may be far larger and
more complex than previously recognized.
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